Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KCTD5 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.004 |
mRNA | DNAJA4 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.004 |
mRNA | PDCD2L | CTRPv2 | pan-cancer | AAC | 0.36 | 0.004 |
mRNA | COX8C | CTRPv2 | pan-cancer | AAC | 0.32 | 0.004 |
mRNA | ZUFSP | CTRPv2 | pan-cancer | AAC | 0.35 | 0.004 |
mRNA | ARV1 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.004 |
mRNA | PLD6 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.004 |
mRNA | SPRYD3 | CTRPv2 | pan-cancer | AAC | -0.36 | 0.004 |
mRNA | INPP5B | CTRPv2 | pan-cancer | AAC | 0.44 | 0.004 |
mRNA | TBC1D3E | CTRPv2 | pan-cancer | AAC | -0.31 | 0.004 |